Early detection

We’re bringing researchers, policy-makers, pharmaceutical
companies and the public together to find a way to make early diagnosis better.

Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string’ test to detect oesophageal cancer earlier.

Researchers have revealed a new blood test that uses artificial intelligence to identify cancer, but it’s not ready for patients yet. 

The idea of taking a small vial of blood and being able to detect cancer at its earliest and most treatable stages is an attractive one.

Poo is an important source of clues when it comes to detecting bowel cancer early. We chat to some of our researchers who are using poo to understand more about what’s going on in the gut.

We speak to our scientists who are developing urine tests that aim to detect bladder and pancreatic cancer earlier.

A successful cancer test needs to reliably detect ‘red-flag’ molecules produced by the cancer and be cheap so it can be used to screen thousands of people.

Diagnosing cancer at its earliest and most treatable stages is vital to help more people survive their cancer. But it requires having enough NHS staff in place.

The roll-out of mobile NHS scanners will save lives from lung cancer. But staff shortages, stop smoking services and treatment inequalities can’t be ignored.

The first clinical trial testing Owlstone’s Breath Biopsy® technology on a range of cancer types is now open.